These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 5591949

  • 1. The effect of methyldopa on the excretion of catecholamines in patients with extrapyramidal disorders.
    Metzel A, Holldorf A, Umbach W.
    Confin Neurol; 1967; 29(2):78-80. PubMed ID: 5591949
    [No Abstract] [Full Text] [Related]

  • 2. [Qualitative analysis of the main urinary metabolites of dopamine, epinephrine and norepinephrine by gas chromatography].
    Bègue RJ, Bazerolle O, Desgres J, Lallemant C, Padieu P.
    Pathol Biol (Paris); 1971; 19(15):719-25. PubMed ID: 4942503
    [No Abstract] [Full Text] [Related]

  • 3. Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. II. Effect on metabolism of L-2- 14 C-dopa.
    Bianchine JR, Messiha FS, Hsu TH.
    Clin Pharmacol Ther; 1972; 13(4):584-94. PubMed ID: 5042372
    [No Abstract] [Full Text] [Related]

  • 4. A three solvent partition chromatographic technique for the estimation of acid metabolites of catecholamines. Urinary DOMA, DOPAC and HVA.
    Vahidi A, Siva Sankar DV.
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):156-60. PubMed ID: 5524313
    [No Abstract] [Full Text] [Related]

  • 5. The urinary output of catecholamines in narcolepsy under resting conditions and following administration of dopamine, DOPA, and DOPS.
    Gunne LM, Lidvall HF.
    Scand J Clin Lab Invest; 1966 Jan; 18(4):425-30. PubMed ID: 5950129
    [No Abstract] [Full Text] [Related]

  • 6. Clinical evaluation of catecholamine excretion.
    Petrásek J, Dubovský J, Charvát J.
    Endokrinologie; 1966 Dec; 50(5):308-16. PubMed ID: 5989933
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Urinary catecholamine excretion following lysergic acid diethylamide in man.
    Hollister LE, Moore F.
    Psychopharmacologia; 1967 Aug 04; 11(3):270-5. PubMed ID: 6059087
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of veloergometric exercise to the limit of endurance on indices of the sympatho-adrenal system in subjects with different degrees of physical training].
    Men'shikov VV, Bol'shakova TD, Erez VP, Lukicheva TI, Dubobes GK.
    Probl Endokrinol (Mosk); 1973 Aug 04; 19(1):45-51. PubMed ID: 4698455
    [No Abstract] [Full Text] [Related]

  • 11. Catecholamines and their acidic metabolites in urine and in tumour tissue in neuroblastoma, ganglioneuroma and phaeochromocytoma.
    Hinterberger H, Bartholomew RJ.
    Clin Chim Acta; 1969 Jan 04; 23(1):169-75. PubMed ID: 5762125
    [No Abstract] [Full Text] [Related]

  • 12. Studies on the metabolism and excretion of L-3,4-dihydroxyphenylalanine (L-DOPA) in human beings by gas chromatography.
    Imai K, Sugiura M, Kubo H, Tamura Z, Oya K.
    Chem Pharm Bull (Tokyo); 1972 Apr 04; 20(4):759-64. PubMed ID: 5045616
    [No Abstract] [Full Text] [Related]

  • 13. HPLC for urinary catecholamines and metanephrines with alpha-methyldopa.
    Munion GL, Seaton JF, Harrison TS.
    J Surg Res; 1983 Dec 04; 35(6):507-14. PubMed ID: 6656240
    [Abstract] [Full Text] [Related]

  • 14. Excretion of catecholamines and catecholamine metabolites in Project Mercury pilots.
    Weil-Malherbe H, Smith ER, Bowles GR.
    J Appl Physiol; 1968 Feb 04; 24(2):146-51. PubMed ID: 5637676
    [No Abstract] [Full Text] [Related]

  • 15. Biochemical changes in psychotic depression. High norepinephrine levels in psychotic vs neurotic depression.
    Bunney WE, Davis JM, Weil-Malherbe H, Smith ER.
    Arch Gen Psychiatry; 1967 Apr 04; 16(4):448-60. PubMed ID: 6022709
    [No Abstract] [Full Text] [Related]

  • 16. [Urinary excretion of 3,4-dihydroxyphenyl-alanine, 3-O-methyldopa, dopamine and homovanillic acid in man. Effects of an inhibitor of decarboxylase of aromatic amino acids (Benserazide) (author's transl)].
    Geissbühler F, Widmer J.
    J Clin Chem Clin Biochem; 1976 Nov 04; 14(11):543-7. PubMed ID: 1003116
    [Abstract] [Full Text] [Related]

  • 17. [Catecholamine metabolism in the tissue of malignant and benign tumors of the sympathetic nervous system].
    Käser H, Türler K, Burri PH.
    Schweiz Med Wochenschr; 1971 Apr 03; 101(13):484-7. PubMed ID: 5558918
    [No Abstract] [Full Text] [Related]

  • 18. Effects of peripheral aromatic L-amino acids decarboxylase inhibitor on L-(2- 14 C)-3,4-dihydroxyphenylalanine metabolism in man.
    Messiha FS, Hsu TH, Bianchine JR.
    Biochem Pharmacol; 1972 Aug 01; 21(15):2144-7. PubMed ID: 4645885
    [No Abstract] [Full Text] [Related]

  • 19. [Catecholamine excretion in children with neurogenic tumors of the mediastinum].
    Stepanov EA, Bukhny AE, Bol'shakova TD, Lukicheva TI.
    Khirurgiia (Mosk); 1972 Jun 01; 48(6):125-8. PubMed ID: 5043043
    [No Abstract] [Full Text] [Related]

  • 20. Imipramine-mediated effects on levodopa metabolism in man.
    Messiha FS, Morgan JP.
    Biochem Pharmacol; 1974 May 15; 23(10):1503-7. PubMed ID: 4847533
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.